Hangzhou Tigermed Consulting Co., Ltd.
HNGZY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $448 | $2,025 | $2,272 | $3,392 |
| Dep. & Amort. | $324 | $306 | $265 | $189 |
| Deferred Tax | $0 | -$14 | -$8 | $44 |
| Stock-Based Comp. | $0 | $0 | $47 | $83 |
| Change in WC | -$268 | -$849 | -$699 | -$191 |
| Other Non-Cash | $594 | -$274 | -$527 | -$2,093 |
| Operating Cash Flow | $1,097 | $1,150 | $1,358 | $1,424 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$357 | -$314 | -$449 | -$369 |
| Net Acquisitions | -$367 | -$357 | -$663 | -$251 |
| Inv. Purchases | -$6,176 | -$2,142 | -$2,203 | -$3,188 |
| Inv. Sales/Matur. | $2,151 | $1,174 | $430 | $1,063 |
| Other Inv. Act. | $10 | -$257 | $95 | -$38 |
| Investing Cash Flow | -$4,739 | -$1,896 | -$2,789 | -$2,783 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$501 | $684 | $1,489 | $492 |
| Stock Issued | $0 | $0 | $24 | $24 |
| Stock Repurch. | -$271 | -$30 | -$427 | -$516 |
| Dividends Paid | -$642 | -$590 | -$432 | -$262 |
| Other Fin. Act. | -$289 | -$72 | $180 | -$394 |
| Financing Cash Flow | -$1,702 | -$8 | $809 | -$163 |
| Forex Effect | -$7 | $9 | $27 | -$60 |
| Net Chg. in Cash | -$5,351 | -$383 | -$596 | -$1,582 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,400 | $7,783 | $8,378 | $9,960 |
| End Cash | $2,048 | $7,400 | $7,783 | $8,378 |
| Free Cash Flow | $740 | $837 | $909 | $1,055 |